This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

A Phase III Trial of Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma (APROMISS)

This study is currently recruiting participants.
See Contacts and Locations
Verified September 2017 by Advenchen Laboratories, LLC
Sponsor:
Information provided by (Responsible Party):
Advenchen Laboratories, LLC
ClinicalTrials.gov Identifier:
NCT03016819
First received: January 6, 2017
Last updated: September 2, 2017
Last verified: September 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2021
  Estimated Primary Completion Date: April 2021 (Final data collection date for primary outcome measure)